Otsuka Holdings Co., Ltd.: all 780 studies

Page 7 of 8. Open to participants first (58), then studies with results posted, then the rest; newest registration first within each.

• A Phase 1, Open-label, Multiple Dose Escalation Trial to Determine Safety and Tolerability of Once Daily OPB-111077 in Subjects With Advanced CancerCompletedNCT01711034Phase 1
• A Safety Study to Evaluate the Use and Effectiveness of a Topical Ointment to Treat Adults With Atopic DermatitisCompletedNCT01702181Phase 1
• A Study of HSP90 Inhibitor AT13387 Alone or in Combination With Abiraterone AcetateCompletedNCT01685268Phase 1/2
• Phase 2 Study to Evaluate the Preliminary Performance of the C13-URA Breath Test Kit in Dyspeptic SubjectsCompletedNCT01677338Phase 2
• Efficacy and Safety Study of Tolvaptan to Treat Patients With Cardiac EdemaCompletedNCT01651156Phase 3
• Efficacy and Safety of Tolvaptan in the Treatment of Cardiac-Induced Edema in Patients With Heart FailureCompletedNCT01618448Phase 3
• A Study of TAS-114 in Combination With S-1 in Patients With Advanced Solid TumorsCompletedNCT01610479Phase 1
• Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male SubjectsCompletedNCT01590901Phase 1
• Effect of Samsca on Control of Hyponatremia and Extracellular Fluid in Cirrhotic Patients With AscitesTerminatedNCT01552590Phase 4
• REnAL denervatIon by ultraSound Transcatheter EmissionCompletedNCT01529372Not applicable
• Adacolumn in Refractory UC Patients TrialCompletedNCT01481142Phase 4
• Evaluate the Efficacy and Safety of Pletaal (Cilostazol) in Subjects With Vasospastic AnginaCompletedNCT01444885Phase 2
• Observational Study in Patients With Autosomal Dominant Polycystic Kidney DiseaseCompletedNCT01430494
• Aripiprazole for the Augmentation of Antidepressant TherapyCompletedNCT01429831Phase 4
• Phase 1, Open-label Trial to Determine Safety of OPB-51602 in Subjects With Advanced CancerCompletedNCT01423903Phase 1
• PRISM Registry: Pseudobulbar Affect Registry SeriesCompletedNCT01366027
• Multiple-dose Pharmacokinetics Study of Tolvaptan Tablets in Chinese Patients With HepatocirrhosisCompletedNCT01359462Phase 1
• A Phase 2, Open-Label Study of Amuvatinib in Combination With Platinum-Etoposide Chemotherapy in Small Cell Lung CancerCompletedNCT01357395Phase 2
• Phase III Study of Tolvaptan Tablet to Treat Cirrhosis AscitesCompletedNCT01349348Phase 3
• Dose Exploring and Setting Study for Tolvaptan to Treat Hepatic Cirrhosis With AscitesCompletedNCT01349335Phase 2
• Efficacy and Safety of Imported Probucol to Treat HyperlipidemiaCompletedNCT01349010Phase 3
• A Study to Investigate the Safety and Efficacy of AT13387, Alone or in Combination With Imatinib, in Patients With GISTCompletedNCT01294202Phase 2
• Retrospective Database Study of Real World Abilify Outcomes in Major Depressive Disorder (MDD)CompletedNCT01284218
• A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic NephropathyCompletedNCT01252056Phase 4
• Hyponatremia Registry for Patients With Euvolemic and Hypervolemic HyponatremiaCompletedNCT01240668
• Study of SGI-1776, a PIM Kinase Inhibitor, in Subjects With Relapsed/Refractory LeukemiasWithdrawnNCT01239108Phase 1
• Post-Authorisation Safety Study of Samsca (Tolvaptan) Used in Routine Medical PracticeStatus unknownNCT01228682
• Open-label, Extension Study of CDP870 in Patients With Rheumatoid ArthritisCompletedNCT01197066Phase 3
• Phase 1, Dose-escalation Trial of OPB-51602 in Patients With Advanced Solid TumorsCompletedNCT01184807Phase 1
• Effect of AT7519M Alone and AT7519M Plus Bortezomib in Patients With Previously Treated Multiple MyelomaCompletedNCT01183949Phase 1/2
• Mucosta in Gastric Ulcer Treatment, Effectiveness and Safety EvaluationCompletedNCT01150162Phase 3
• Impact of Atypical Antipsychotic Therapy on Health Outcomes and Costs Among Patients With Major Depressive DisorderCompletedNCT01145313
• Evaluation of Concomitant Administration of Cilostazol and Probucol on Biomarkers, Endothelial Function and SafetyCompletedNCT01142284Phase 2
• The Effect of Patient Cost-Sharing on Antidepressant and Adjunctive Therapy UseCompletedNCT01141400
• Outcomes in MEasurement-Based TreatmentCompletedNCT01141387
• A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler and Berotec N® Metered Aerosol in Mild to Moderate Stable Asthma PatientsCompletedNCT01095016Phase 3
• Comparative Study on the Efficacy and Safety of Procaterol Versus Salbutamol Given Via Metered Dose Inhaler With Spacer in the Management of Acute Asthma Attack in the Emergency RoomCompletedNCT01091337Phase 4
• Asian Study on Cilostazol Effectivity in Neuropathies of Diabetes Mellitus Type 2-A Pilot Study in the PhilippinesCompletedNCT01076478Phase 4
• A Study to Evaluate the Efficacy and Safety of Meptin® Swinghaler® and Ventolin® MDI in Stable Asthma PatientsCompletedNCT01076322Phase 3
• Safety and Pharmacokinetic Study of C13-URA in Healthy VolunteersCompletedNCT01074710Phase 1
• Pharmacokinetics/Pharmacodynamics (PK/PD) Characteristics of Tolvaptan Tablet in Korean Healthy MaleCompletedNCT01014416Phase 1
• Pharmacokinetics Study for ProbucolCompletedNCT01000467Phase 4
• Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic GastritisCompletedNCT00996788Phase 3
• Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute AsthmaCompletedNCT00990847Phase 3
• A Study to Evaluate Efficacy and Safety Effects Using Mikelan® LA Ophthalmic Solution (OS) 2% Versus Timoptol® XE Ophthalmic Solution (OS) 0.5% in Ocular Hypertension PatientsCompletedNCT00972426Phase 4
• Open-label Investigation of the Safety and Effectiveness of DIABECELL(R) in Patients With Type I Diabetes MellitusCompletedNCT00940173Phase 1/2
• Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetics and Pharmacodynamics of Oral MP470, a Multitargeted Tyrosine Kinase Inhibitor, in Patients With Solid MalignanciesCompletedNCT00894894Phase 1
• Study of S-1 Plus LV for Untreated Metastatic Colorectal CancerCompletedNCT00891332Phase 2
• Safety of MP470 in Combination With Standard-of-Care Chemotherapy Regimens to Treat Solid TumorsCompletedNCT00881166Phase 1
• Study to Assess the Safety of Escalating Doses of AT13387 in Patients With Metastatic Solid TumorsCompletedNCT00878423Phase 1
• Safety of SGI-1776, A PIM Kinase Inhibitor in Refractory Prostate Cancer and Relapsed/Refractory Non Hodgkin's LymphomaTerminatedNCT00848601Phase 1
• Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study SubjectCompletedNCT00823875Phase 4
• Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related BiomarkerCompletedNCT00823849Phase 4
• Positron Emission Tomagraphy (PET) Study Following a Single Oral Dose of OPC-34712CompletedNCT00805454Phase 1
• Phase I/II Study of TSU-68 for Advanced Hepatocellular CarcinomaCompletedNCT00784290Phase 1/2
• ADAPT Adacolumn Pediatric Trial in Ulcerative ColitisCompletedNCT00781638Not applicable
• A Mono-center Study in Healthy Volunteers on the Comparative Bioavailability of Pletal 100 mg Tablets and a New Pletal 100 mg Orodispersible Tablet (ODT), This Latter in Fasting Conditions With and Without Water and Under Fed ConditionsCompletedNCT00773630Phase 1
• Cilostazol Stroke Prevention Study : A Placebo-controlled Double-blind Trial for Secondary Prevention of Cerebral Infarction.CompletedNCT00766545Phase 3
• A Study of TAC-101 in Combination With TACE Versus TACE Alone in Asian Patients With Advanced Hepatocellular CarcinomaWithdrawnNCT00756782Phase 2
• Randomized Phase II Study of SOL for Untreated Metastatic Colorectal CancerCompletedNCT00721916Phase 2
• Comparative Study of Aripiprazole and Olanzapine in the Treatment of Patients With Acute SchizophreniaCompletedNCT00712686Phase 3
• A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute HyponatremiaCompletedNCT00664014Phase 2
• Phase II Study of ABI-007 for Gastric CancerCompletedNCT00661167Phase 2
• An Open-Label Phase-1 Study of OPB-31121 in Patients With Advanced Solid TumorsStatus unknownNCT00657176Phase 1
• Phase 2 Study of S-1 as 2nd Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00652561Phase 2
• Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic CancerCompletedNCT00652054Phase 2
• Phase 2 Study of S-1 in Combination With Cisplatin as 1st Line Therapy in Advanced Non-Small Cell Lung CancerCompletedNCT00651833Phase 2
• Randomized Double-Blind Clinical Trial of Rebamipide vs Esomeprazole in the Treatment of NSAID-induced GastropathyCompletedNCT00641004Phase 4
• PReventive Efficacy and Safety of rEbamipide on Nsaid Induced Mucosal ToxicityCompletedNCT00576706Phase 3
• Phase II Trial of Combination Therapy With Irinotecan, S-1, and Bevacizumab (IRIS/Bev) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569790Phase 2
• Phase II Trial of Combination Therapy With Bevacizumab and S-1 in Elderly Patients With Unresectable or Recurrent Colorectal Cancer (BASIC)CompletedNCT00569699Phase 2
• Phase II Trial of Combination Therapy With S-1, Irinotecan, and Bevacizumab (SIRB) in Patients With Unresectable or Recurrent Colorectal CancerCompletedNCT00569335Phase 2
• Safety and Pharmacokinetics of Probucol and CilostazolCompletedNCT00549978Phase 4
• Observational Study of Anti-Cancer Therapy Induced Oral Mucositis in Korean Cancer PatientsStatus unknownNCT00549952
• Abilify in Bipolar Disorder for 24 Weeks Treatment EffectivenessCompletedNCT00545675Phase 4
• Abilify in Bipolar Disorder for 6 Weeks Treatment EffectivenessCompletedNCT00545142Phase 4
• A Phase II Study of a Continuous Hepatic Arterial Infusion Combination Therapy With OPC-18 and 5-FU in Patients With Highly Advanced Hepatocellular CarcinomaCompletedNCT00524498Phase 2
• Study to Assess the Safety of Escalating Doses of AT9283, in Patients With LeukemiasTerminatedNCT00522990Phase 1/2
• Health Evaluation of Abilify Long-term TherapyCompletedNCT00520650Phase 4
• Phase 1 Study of OPB-31121 in Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma or Multiple MyelomaCompletedNCT00511082Phase 1
• MP470 in Treating Patients With Unresectable or Metastatic Solid Tumor or LymphomaTerminatedNCT00504205Not applicable
• Phase III of Gemcitabine Vs TS-1 Vs Gemcitabine Plus TS-1 in Pancreatic CancerCompletedNCT00498225Phase 3
• ABLE: Abilify in Bipolar Disorder for Long-term EffectivenessCompletedNCT00484471Phase 4
• Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary TuberculosisCompletedNCT00401271Phase 2
• A Phase 1, Open-Label, Randomized, Cross-Over, Pharmacokinetic Study Evaluating the Effect of S-1 on Advanced Solid TumorsCompletedNCT00400023Phase 1
• Evaluating Patients With Impaired Hepatic FunctionCompletedNCT00398424Phase 1
• Evaluating Patients With Varying Degrees of Renal FunctionCompletedNCT00398307Phase 1
• Tiotropium + Procaterol vs Tiotropium + Placebo in COPD PatientsTerminatedNCT00394485Phase 4
• CESA 5.10 Investigation to Compare the Efficacy and Safety of the Adacolumn® Apheresis Device in Patients With Active Ulcerative ColitisCompletedNCT00366925Not applicable
• Aripiprazole and Effexor XR Drug Interaction StudyCompletedNCT00362271Phase 1
• Aripiprazole and Lexapro Drug Interaction StudyCompletedNCT00361790Phase 1
• Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic ChemotherapyCompletedNCT00359567Phase 3
• A Study of Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive EpisodeWithdrawnNCT00338273Phase 3
• Effect on Cognitive Function of a Treatment With AripiprazoleCompletedNCT00329810Phase 4
• Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.CompletedNCT00325689Phase 4
• Drug-drug Interaction Study of Aripiprazole and Lamotrigine in Patients With Bipolar Type I DisorderCompletedNCT00321516Phase 1
• Acute Psychosis Treatment in the Long Term, Unitary Group Study (APLUS)CompletedNCT00304655Phase 4
• SWitching to Abilify Trial (SWAT)CompletedNCT00304616Phase 4
• A Study of Adjunctive Treatment of Aripiprazole in Schizophrenic PatientsCompletedNCT00300846Phase 4
• A Study of Aripiprazole in Patients With Schizophrenia in General Psychiatric PracticesCompletedNCT00292409Phase 3

← Otsuka Holdings Co., Ltd. overview and focus areas